BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $34,777,000 | +26.7% | 238,670 | +3.1% | 1.38% | +51.5% |
| Q1 2022 | $27,453,000 | -33.6% | 231,537 | -22.8% | 0.91% | -26.3% |
| Q4 2021 | $41,339,000 | +248.0% | 299,972 | +250.8% | 1.24% | +237.3% |
| Q3 2021 | $11,880,000 | -61.4% | 85,520 | -73.1% | 0.37% | -60.0% |
| Q2 2021 | $30,808,000 | +39.9% | 317,348 | -1.5% | 0.92% | +29.5% |
| Q1 2021 | $22,015,000 | +22.9% | 322,087 | +54.1% | 0.71% | +19.4% |
| Q4 2020 | $17,909,000 | +34.0% | 208,946 | +1.6% | 0.59% | +2.2% |
| Q3 2020 | $13,367,000 | -19.2% | 205,620 | -9.1% | 0.58% | -21.8% |
| Q2 2020 | $16,543,000 | – | 226,282 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |